BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29622765)

  • 1. Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.
    Choi JH; Kim YB; Ahn JM; Kim MJ; Bae WJ; Han SU; Woo HG; Lee D
    Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29622765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
    Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
    Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
    BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic alterations in gastric cancers discovered via whole-exome sequencing.
    Zhang J; Qiu W; Liu H; Qian C; Liu D; Wang H; Hu N; Tang YT; Sun J; Shen Z
    BMC Cancer; 2018 Dec; 18(1):1270. PubMed ID: 30567531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine.
    Röcken C; Amallraja A; Halske C; Opasic L; Traulsen A; Behrens HM; Krüger S; Liu A; Haag J; Egberts JH; Rosenstiel P; Meißner T
    Genome Med; 2021 Nov; 13(1):177. PubMed ID: 34749812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexisting genomic aberrations associated with lymph node metastasis in breast cancer.
    Bao L; Qian Z; Lyng MB; Wang L; Yu Y; Wang T; Zhang X; Yang H; Brünner N; Wang J; Ditzel HJ
    J Clin Invest; 2018 Jun; 128(6):2310-2324. PubMed ID: 29558370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.
    Pang L; Wang J; Fan Y; Xu R; Bai Y; Bai L
    Cancer Biomark; 2018; 23(1):53-59. PubMed ID: 30010108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
    Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
    World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational landscape of paired primary and synchronous metastatic lymph node in chemotherapy naive gallbladder cancer.
    Fan B; Xu X; Wang X
    Mol Biol Rep; 2022 Feb; 49(2):1295-1301. PubMed ID: 34988893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics.
    Wang H; Ding Y; Chen Y; Jiang J; Chen Y; Lu J; Kong M; Mo F; Huang Y; Zhao W; Fang P; Chen X; Teng X; Xu N; Lu Y; Yu X; Li Z; Zhang J; Wang H; Bao X; Zhou D; Chi Y; Zhou T; Zhou Z; Chen S; Teng L
    Gastric Cancer; 2021 Nov; 24(6):1227-1241. PubMed ID: 34095982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations.
    Nikaido M; Kakiuchi N; Miyamoto S; Hirano T; Takeuchi Y; Funakoshi T; Yokoyama A; Ogasawara T; Yamamoto Y; Yamada A; Setoyama T; Shimizu T; Kato Y; Uose S; Sakurai T; Minamiguchi S; Obama K; Sakai Y; Muto M; Chiba T; Ogawa S; Seno H
    Gastric Cancer; 2021 Sep; 24(5):1102-1114. PubMed ID: 33961152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges.
    Garcia-Pelaez J; Barbosa-Matos R; Gullo I; Carneiro F; Oliveira C
    Mol Oncol; 2021 Nov; 15(11):2841-2867. PubMed ID: 33724653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic features of Helicobacter pylori-naïve diffuse-type gastric cancer.
    Namikawa K; Tanaka N; Ota Y; Takamatsu M; Kosugi M; Tokai Y; Yoshimizu S; Horiuchi Y; Ishiyama A; Yoshio T; Hirasawa T; Amino S; Furuya R; Gotoh O; Kaneyasu T; Nakayama I; Imamura Y; Noda T; Fujisaki J; Mori S
    J Pathol; 2022 Nov; 258(3):300-311. PubMed ID: 36111561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of lymph node metastasis in early gastric carcinomas diagnosed by WHO criteria in 379 Chinese patients.
    Fang C; Shi J; Sun Q; Gold JS; Xu GF; Liu WJ; Zou XP; Huang Q
    J Dig Dis; 2016 Aug; 17(8):526-537. PubMed ID: 27434552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization.
    Kuroda A; Tsukamoto Y; Nguyen LT; Noguchi T; Takeuchi I; Uchida M; Uchida T; Hijiya N; Nakada C; Okimoto T; Kodama M; Murakami K; Matsuura K; Seto M; Ito H; Fujioka T; Moriyama M
    PLoS One; 2011; 6(7):e22313. PubMed ID: 21811585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo CRISPR-Cas9 knockout screening using quantitative PCR identifies thymosin beta-4 X-linked that promotes diffuse-type gastric cancer metastasis.
    An HW; Kim SY; Kwon JW; Seok SH; Woo SH; Kim DY; Park JW
    Mol Carcinog; 2021 Sep; 60(9):597-606. PubMed ID: 34081824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation heterogeneity between primary gastric cancers and their matched lymph node metastases.
    Lee HH; Kim SY; Jung ES; Yoo J; Kim TM
    Gastric Cancer; 2019 Mar; 22(2):323-334. PubMed ID: 30132154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copy number alterations and epithelial‑mesenchymal transition genes in diffuse and intestinal gastric cancers in Mexican patients.
    Larios-Serrato V; Martínez-Ezquerro JD; Valdez-Salazar HA; Torres J; Camorlinga-Ponce M; Piña-Sánchez P; Ruiz-Tachiquín ME
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35362543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer.
    Moridnia A; Tabatabaiefar MA; Zeinalian M; Minakari M; Kheirollahi M; Moghaddam NA
    J Gastrointest Cancer; 2019 Sep; 50(3):420-427. PubMed ID: 29577179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.